QIAGEN's common shares added to U.S. Russell indexes

QIAGEN N.V. (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) today announced that its common shares were added to the U.S. large-cap Russell 1000 Index and the broad-market Russell 3000 Index. This change came into effect when Russell Investments reconstituted its equity indexes after the close of markets on June 24, 2011. The Russell indexes are widely used by participants in the capital markets, including index funds and as portfolio benchmarks for investment strategies.

"We are pleased that QIAGEN's common shares have been included in the Russell indexes. This inclusion provides further support and liquidity for QIAGEN's common shares, and thereby more benefits to participating in QIAGEN's growth and creation of value for shareholders," said Peer M. Schatz, CEO of QIAGEN.

QIAGEN common shares have traded on The NASDAQ Stock Market since the Company's initial public offering on June 28, 1996, and on the Prime Standard Segment of the Frankfurt Stock Exchange since January 1, 2003.

Source:

Qiagen N V

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Qiagen. (2019, June 20). QIAGEN's common shares added to U.S. Russell indexes. News-Medical. Retrieved on August 02, 2021 from https://www.news-medical.net/news/20110628/QIAGENs-common-shares-added-to-US-Russell-indexes.aspx.

  • MLA

    Qiagen. "QIAGEN's common shares added to U.S. Russell indexes". News-Medical. 02 August 2021. <https://www.news-medical.net/news/20110628/QIAGENs-common-shares-added-to-US-Russell-indexes.aspx>.

  • Chicago

    Qiagen. "QIAGEN's common shares added to U.S. Russell indexes". News-Medical. https://www.news-medical.net/news/20110628/QIAGENs-common-shares-added-to-US-Russell-indexes.aspx. (accessed August 02, 2021).

  • Harvard

    Qiagen. 2019. QIAGEN's common shares added to U.S. Russell indexes. News-Medical, viewed 02 August 2021, https://www.news-medical.net/news/20110628/QIAGENs-common-shares-added-to-US-Russell-indexes.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
Clarient adopts QIAGEN’s therascreen KRAS test to diagnose colorectal cancer